1-20 of 25
Paul J. Bröckelmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PET-Guided Brecadd in Older Patients with Advanced-Stage Classic Hodgkin Lymphoma: Results of the Phase 2 Part of the GHSG HD21 Trial

Justin Ferdinandus, Helen Kaul, Alexander Fosså, Andreas Hüttmann, Felix Keil, Yon-Dschun Ko, Felicitas Hitz, Michaela Schwarz, Corinna Trenker, Andrea Kerkhoff, Peter Staib, Kai Wille, Irmgard Dresel, Dennis Hahn, Bernd Hertenstein, Peter Moosmann, Ulrich Mey, Stefan Balabanov, Tasman Armytage, Fernando Roncolato, Johannes Christian Hellmuth, Stefanie Kreissl, Michael Fuchs, Gundolf Schneider, Hishan Tharmaseelan, Dennis A Eichenauer, Bastian von Tresckow, Peter Borchmann, Paul J. Bröckelmann
Journal: Blood
Blood (2024) 144 (Supplement 1): 568.
https://doi.org/10.1182/blood-2024-207946
Published: 2024
Journal Articles

Abscopal Effect of Radiotherapy and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma: Results of the International GHSG Phase II Aern Trial

Paul J. Bröckelmann, Ina Bühnen, Josée M Zijlstra, Stephan Mathas, Katrin S Roth, Maria Garcia-Marquez, Christian Sillaber, Julia Meissner, Alexander Fossa, Richard Greil, Karolin Trautmann-Grill, Johannes Rosenbrock, Wouter Plattel, Hans A Schlösser, Carsten Kobe, Michael Fuchs, Peter Borchmann, Christian Baues
Journal: Blood
Blood (2024) 144 (Supplement 1): 4428.
https://doi.org/10.1182/blood-2024-202113
Published: 2024
Journal Articles

Targeting Lymphoma Associated Myeloid-Monocytic Cells through CSF1R Blockade Enhances CAR-T Cell Response in Aggressive B Cell Lymphoma

David Stahl, Philipp Gödel, Hyatt Balke-Want, Paul Segbers, Luis Tetenborg, Rahil Gholamipoorfard, Daniel Bachurski, France Rose, Zinaida Good, Adrian G. Simon, Marieke Nill, Ruth Flümann, Tobias Riet, Janina Dörr, Stuart J. Blakemore, Herrad Baurmann, Conrad-Amadeus Voltin, Nicole Potter, Lilli Schlözer, Svenja Wagener-Ryczek, Andra-Iza Iuga, Jan-Michel Heger, Hanna Ludwig, Julia K. Schleifenbaum, Paul J. Bröckelmann, Ron D. Jachimowicz, Gero Knittel, Sven Borchmann, Sabine Merkelbach-Bruse, Christian Pallasch, Martin Peifer, Mark Nitz, Johannes Brägelmann, Werner Müller, Thorsten Persigehl, Katarzyna Bozek, Reinhard Büttner, Michael J. Hallek, Sebastian Kobold, Markus Chmielewski, Hans Christian Reinhardt, Crystal L. Mackall, Nima Abedpour, Peter Borchmann, Roland T. Ullrich
Journal: Blood
Blood (2024) 144 (Supplement 1): 367.
https://doi.org/10.1182/blood-2024-203291
Published: 2024
Journal Articles

Brentuximab Vedotin, Cyclophosphamide, Doxorubicin and Prednisone (B-CAP) First-Line Treatment of Advanced-Stage Hodgkin Lymphoma: Final Results of the GHSG-NLG Phase II Bvb Trial

Paul J. Bröckelmann, Boris Böll, Daniel Molin, Gundolf Schneider, Sirpa Leppä, Julia Meissner, Peter Kamper, Martin Hutchings, Jacob Haaber Christensen, Ulf Schnetzke, Michael Fuchs, Dennis A Eichenauer, Bastian von Tresckow, Helen Kaul, Peter Borchmann, Alexander Fossa
Journal: Blood
Blood (2024) 144 (Supplement 1): 3054.
https://doi.org/10.1182/blood-2024-202120
Published: 2024
Journal Articles

Serum TARC Dynamics Correlate with Clinical Response and Metabolic Tumor Volume during Anti-PD1-Based First-Line HL Treatment in the GHSG Phase II Nivahl Trial

Paul J. Bröckelmann, Sophie Teesink, Lydia Visser, Conrad-Amadeus Voltin, Helen Kaul, Hans Schlösser, Bart-Jan Kroesen, Carsten Kobe, Peter Borchmann, Arjan Diepstra, Wouter Plattel
Journal: Blood
Blood (2024) 144 (Supplement 1): 3044.
https://doi.org/10.1182/blood-2024-201547
Published: 2024
Journal Articles

Outcomes of Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Multicenter Real-World Analysis

Philipp Berning, David Baden, Philipp Faustmann, Snjezana Janjetovic, Hanna Katharina Zieger, Jan Christian Schroeder, Giuliano Filippini Velazquez, Anna Ossami Saidy, Hristo Boyadzhiev, Tim Sauer, Jan-Henrik Mikesch, Niklas Gebauer, Susanne Ghandili, Paul J. Bröckelmann, Friederike Hildebrand, Veit L. Buecklein, Rebecca Wurm-Kuczera, Ulrich Keller, Georg Lenz, Thomas Pabst, Thomas Melchardt, Claudia Lengerke, Maher Hanoun, Evgenii Shumilov, Ulrike Bacher
Journal: Blood
Blood (2024) 144 (Supplement 1): 3818.
https://doi.org/10.1182/blood-2024-211227
Published: 2024
Journal Articles

Patterns of Disease in Early Stage Favorable Hodgkins Lymphoma

Hishan Tharmaseelan, Janina Jablonski, Ina Bühnen, Johannes Rosenbrock, Paul J. Bröckelmann, Justin Ferdinandus, Peter Borchmann
Journal: Blood
Blood (2024) 144 (Supplement 1): 3050.
https://doi.org/10.1182/blood-2024-200035
Published: 2024
Journal Articles

Dissection of Single-Cell Landscapes for the Development of Chimeric Antigen Receptor T Cells in Hodgkin Lymphoma

Adrian Gottschlich, Ruth Grünmeier, Gordon Victor Hoffmann, Sayantan Nandi, Vladyslav Kavaka, Philipp Jie Müller, Jakob Jobst, Arman Öner, Rainer Kaiser, Jan Gärtig, Ignazio Piseddu, Stephanie Frenz-Wiessner, Heiko Schulz, Lea Di Fina, Maité Mulkers, Moritz Thomas, Veronika Igl, Thomas Alexander Janert, Daria Briukhovetska, Donjetë Simnica, Emanuele Carlini, Christina Tsiverioti, Marcel Trefny, Theo Lorenzini, Florian Märkl, Ruben Brabenec, Thaddäus Strzalkowski, Sophia Stock, Stefanos Michaelides, Irmela Jeremias, Johannes Christian Hellmuth, Martin Thelen, Sarah Reinke, Wolfram Klapper, Pascal Gelebart, Leo Nicolai, Carsten Marr, Eduardo Beltrán, Christoph Klein, Fanny Baran-Marszak, Paul J. Bröckelmann, Andreas Rosenwald, Michael von Bergwelt-Baildon, Stefan Endres, Sebastian Kobold
Journal: Blood
Blood (2024) 144 (Supplement 1): 4796.
https://doi.org/10.1182/blood-2024-207274
Published: 2024
Journal Articles

Epi(geneti)c makeover: boosting anti-PD-1 in HL

Paul J. Bröckelmann
Journal: Blood
Blood (2024) 144 (18): 1850–1852.
https://doi.org/10.1182/blood.2024026162
Published: 2024
Journal Articles

Correlation between Progression-Free Survival and Overall Survival in Patients with Relapsed Hodgkin Lymphoma: An Analysis of Individual Patient Data from Randomized GHSG Trials

Paul J Bröckelmann, Horst Müller, Sarah Gillessen, Anne Sophie Jacob, Jesko Momotow, Carla Damaschin, Justin Ferdinandus, Xiaoqin Yang, Michael Fuchs, Carsten Kobe, Hans Theodor Eich, Andreas Engert, Peter Borchmann, Bastian von Tresckow
Journal: Blood
Blood (2023) 142 (Supplement 1): 3070.
https://doi.org/10.1182/blood-2023-188622
Published: 2023
Journal Articles

Fertility and Gonadal Function after First-Line Treatment with Nivolumab-AVD in Hodgkin Lymphoma Patients: An Analysis from the Phase II GHSG Nivahl Trial

Paul J Bröckelmann, Ina Bühnen, Peter Herhaus, Julia Meissner, Karolin Trautmann-Grill, Horst Müller, Michael Fuchs, Bastian von Tresckow, Peter Borchmann, Andreas Engert, Karolin Behringer
Journal: Blood
Blood (2023) 142 (Supplement 1): 4456.
https://doi.org/10.1182/blood-2023-189250
Published: 2023
Journal Articles

Contrasting Features of T-Cell Expansion in Classical Hodgkin Lymphoma: Tumor Microenvironment Vs. Peripheral Blood and before Vs. during Anti-PD1 Treatment

Nicole Seifert, Sarah Reinke, Johanna Grund, Berit Müller-Meinhard, Andreas Engert, Peter Borchmann, Paul J Bröckelmann, Michael Altenbuchinger, Wolfram Klapper
Journal: Blood
Blood (2023) 142 (Supplement 1): 3018.
https://doi.org/10.1182/blood-2023-186527
Published: 2023
Journal Articles

Quality of Life with Nivolumab and AVD First-Line Treatment in Hodgkin Lymphoma: Patient-Reported Outcomes from the Phase II GHSG Nivahl Trial

Paul J Bröckelmann, Ina Bühnen, Peter Herhaus, Julia Meissner, Karolin Trautmann-Grill, Horst Müller, Michael Fuchs, Bastian von Tresckow, Peter Borchmann, Andreas Engert, Karolin Behringer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1710.
https://doi.org/10.1182/blood-2023-188734
Published: 2023
Journal Articles

AXL-erating mantle cell lymphoma treatment

Paul J. Bröckelmann
Journal: Blood
Blood (2023) 142 (17): 1411–1412.
https://doi.org/10.1182/blood.2023021455
Published: 2023
Journal Articles

Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Follow-up Analysis of the Randomized GHSG Phase II Nivahl Trial

Paul J Bröckelmann, Ina Bühnen, Julia Meissner, Karolin Trautmann-Grill, Peter Herhaus, Teresa V Halbsguth, Valdete Schaub, Andrea Kerkhoff, Stephan Mathas, Matthias Bormann, Andreas Dickhut, Helen Kaul, Michael Fuchs, Carsten Kobe, Christian Baues, Peter Borchmann, Andreas Engert, Bastian von Tresckow
Journal: Blood
Blood (2022) 140 (Supplement 1): 1753–1755.
https://doi.org/10.1182/blood-2022-168846
Published: 2022
Journal Articles

Outcomes of Anti-PD1 Treatment for Relapsed/Refractory Hodgkin Lymphoma: A German Hodgkin Study Group (GHSG) Multi-Center Real-World Analysis

Jesko Momotow, Ina Bühnen, Karolin Trautmann-Grill, Guido Kobbe, Martin Wilhelm, Bernhard Heinrich, Tobias Gaska, Helmut Forstbauer, Burkhard Schmidt, Andreas Hüttmann, Gerhard Heil, Doris M. Kraemer, William Hermann Krüger, Vanja Zeremski, Norbert Grobe, Kathleen Jentsch-Ulrich, Michael Fuchs, Bastian von Tresckow, Peter Borchmann, Andreas Engert, Paul J Bröckelmann
Journal: Blood
Blood (2021) 138 (Supplement 1): 4533.
https://doi.org/10.1182/blood-2021-153200
Published: 2021
Journal Articles

Impact of Timing and Precision of Histopathological Diagnosis on Outcomes of Patients with Burkitt and High-Grade B-Cell Lymphoma

Jan-Michel Heger, Claus Moritz Graef, Philipp Falderbaum, Philipp Gödel, Hyatt Balke-Want, Florian Simon, Noëlle Sieg, Jan-Hendrik Naendrup, Marie Anne-Catherine Neumann, Sarah Gillessen, Paul J Bröckelmann, Dennis A. Eichenauer, Peter Borchmann, Bastian Von Tresckow
Journal: Blood
Blood (2021) 138 (Supplement 1): 2531.
https://doi.org/10.1182/blood-2021-145283
Published: 2021
Journal Articles

Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1

Sarah Reinke, Paul J. Bröckelmann, Ingram Iaccarino, Maria Garcia-Marquez, Sven Borchmann, Franziska Jochims, Michaela Kotrova, Karol Pal, Monika Brüggemann, Elena Hartmann, Stephanie Sasse, Carsten Kobe, Stephan Mathas, Martin Soekler, Ulrich Keller, Matthias Bormann, Andreas Zimmermann, Julia Richter, Michael Fuchs, Bastian von Tresckow, Peter Borchmann, Hans Schlößer, Michael von Bergwelt-Baildon, Andreas Rosenwald, Andreas Engert, Wolfram Klapper
Journal: Blood
Blood (2020) 136 (25): 2851–2863.
https://doi.org/10.1182/blood.2020008553
Published: 2020
Includes: Supplemental data
Journal Articles

Efficacy and Safety of Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Extended Follow-up from the GHSG Phase II Nivahl Trial

Paul J Bröckelmann, MD, Helen Goergen, Dipl.-Math., Ulrich Keller, Julia Meissner, MD, Karolin Trautmann, MD, Teresa V Halbsguth, MD, Stephanie Sasse, MD, Martin Sökler, MD, Andrea Kerkhoff, MD, Stephan Mathas, MD, Andreas Hüttmann, MD, Matthias Bormann, MD, Andreas Zimmermann, MD, Michael Fuchs, Bastian von Tresckow, MD, Christian Baues, MD, Andreas Rosenwald, MD, Wolfram Klapper, MD, Carsten Kobe, MD, Peter Borchmann, MD, Andreas Engert, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-138413
Published: 2020
Journal Articles

Nivolumab and AVD for Early-Stage Unfavorable Hodgkin Lymphoma (NIVAHL)

Paul J Bröckelmann, MD, Helen Goergen, Dipl.-Math., Ulrich Keller, MD, Julia Meissner, MD, Rainer Ordemann, MD, Teresa V Halbsguth, MD, Stephanie Sasse, MD, Martin Sökler, MD, Andrea Kerkhoff, MD, Stephan Mathas, MD, Andreas Hüttmann, MD, Matthias Bormann, MD, Andreas Zimmermann, MD, Michael Fuchs, MD, Bastian von Tresckow, Christian Baues, MD, Andreas Rosenwald, MD, Wolfram Klapper, Carsten Kobe, Peter Borchmann, MD PhD, Andreas Engert, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 236.
https://doi.org/10.1182/blood-2019-122406
Published: 2019